Abstract. The 
T4 (4.1 \ m=+-\0.53 vs. 0.8 \ m=+-\0.27 \g=m\g/100 ml, P < 0.005) and T3 (77.3 \ m=+-\3.2 vs. 41.7 \m=+-\12.1 ng/100 ml, P < 0.05) were lower in diabetic rats than in controls. Hepatic concentration of non-protein sulfhydryl-groups was also moderately (\m=~\19%) lower in diabetic rats than in controls (4.62 \m=+-\0.11vs. 3.75 \ m=+-\0.24 \g=m\mol/g, P < 0.02). The maximal binding capacity (MBC) (Naeye et al. 1978; Pittman et al. 1979a ). The extrathyroidal deiodination of thyroxine (T4) is consistently impaired. The 'low T3, high reverse T3 (rT3)' syndrome of non-thyroid illness has been documented in several studies of diabetic patients (Naeye et al. 1978; Saunders et al. 1978) . Its occurrence has been explained on the basis of an impaired production of triiodothyronine (T3) from metabolism of T4 and a decreased metabolic clear¬ ance rate of rT3, both apparently due to a reduc¬ tion in the activity of iodothyronine 5'-monodeiodinase (Pittman et al. 1979b (Bradford 1976) ; the mean ratio of protein to DNA was 3.7 ± 0.27. (Soeldner & Slone 1965) and plasma glucagon (Unger et al. 1970) by radioimmunoassay (the glucaon assays using the 31K antibody were kindly performed by Dr (Chopra 1972 ) and serum T3 
Results
The streptozotocin-treated rats gained less weight during the study period than the control animals, (Fig. 2) . The data on relative influence of various SH reagents on nuclear binding of T3 are shown in Fig. 3 
